FDA Delays Popular Nicotine Pouches Over Youth Risks
Popular nicotine pouches like Zyn and Velo remain unapproved in the US despite FDA fast-track. Agency hesitates due to rising youth use and addiction concerns.
NOTRELOAD AI
FDA Just Approved Foundayo: The Only GLP-1 Weight-Loss Pill You Can Take Anytime, Anywhere
Eli Lilly’s Foundayo (orforglipron) is now FDA-approved — the only GLP-1 pill for weight loss you can take any time of day, with or without food or water. Average 27 lb loss.
Wells Fargo Sees Sharp Recovery for Boeing – Starts with Overweight
Wells Fargo starts coverage on Boeing with an Overweight rating and $250 price target. Strong free cash flow recovery expected as MAX and 787 production ramps up.
Intel Soars After $14.2B Buyback of Irish Chip Factory
Intel will repurchase its 49% stake in Ireland’s Fab 34 from Apollo for $14.2B. Stock jumps as the chipmaker regains full control of key AI manufacturing site.
Cyclerion Stock Soars on $380M Merger with Korsana to Fight Alzheimer’s
Cyclerion stock surges after announcing a merger with Korsana Biosciences and $380M in new funding to advance a next-gen Alzheimer’s antibody.
Benchmark Sees Huge Upside in Snowflake, Microsoft & Cybersecurity Leaders
Benchmark initiates Buy coverage on Snowflake, Microsoft, Palo Alto Networks, ServiceNow, and CrowdStrike.